Delivery Order SPE2DB22D3004-SPE2DB25FRY64
- Not listed
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a $2,619.29 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexamethasone 10 mg/mL vials. This competitively awarded, firm fixed-price delivery order is set to conclude on August 13, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,343.25. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Department of Defense's Medical Supply Chain issued a delivery order (Contract No. 4568944715) to AmerisourceBergen Drug Corp for the supply of Dexamethasone 30ML on July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,784.46 and is scheduled for completion by August 27, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,113.35 for 100 tablets of Dexamethasone 4 mg, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, employs firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $5,681.22 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dexamethasone 0.5 mg/5 ml elixir in a 237 ml quantity, with an ultimate completion date of August 21, 2025. This competitively awarded contract utilizes firm fixed-price pricing and does not include a set-aside designation. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a $4,131.41 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dexamethasone 0.5 mg/5 mL elixir in a 237 mL quantity, with ultimate completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,837.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 0.5 mg/5 mL elixir (237 mL), with an ultimate completion date of August 11, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.80 to AmerisourceBergen Drug Corp for Dexamethasone 4 mg tablets in unit dose packages of 100 units. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used across military and federal...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRY64Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,223.52 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract involves the delivery of a corticosteroid medication commonly utilized across military and federal healthcare systems for anti-inflammatory and immunosuppressant applications. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to meet federal procurement requirements through open competition and serves critical federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/12/25 |